Activation and up-regulation of translation initiation factor 4B contribute to arsenic-induced transformation

Molecular Carcinogenesis

Volumn 50, Issue 7, 2011, Pages 528-538

  Zhang, Yong ^a,b   Wang, Qing ^a   Guo, Xiaoling ^a,c   Miller, Robert ^a   Guo, Yinglu ^b   Yang, Hsin Sheng ^a,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c SHANDONG UNIVERSITY   (China)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Arsenic; C Myc; EIF4B; Transformation

Indexed keywords

ARSENITE SODIUM; INITIATION FACTOR 4B; MYC PROTEIN; PROTEIN KINASE B; RIBOSOME PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME REGULATION; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; LONG TERM CARE; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ARSENIC; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EUKARYOTIC INITIATION FACTORS; GENE KNOCKDOWN TECHNIQUES; GENES, MYC; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES; UP-REGULATION;

EID: 79958232708     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20733     Document Type: Article

References (40)

1. IARC. Monographs on evaluation of carcinogenic risk to humans. Some drinking water disinfectants and contaminants, including arsenic. Volume 84. Lyon: IARC Press; 2004. p 269-477.
2. Chen Y, Megosh LC, Gilmour SK, Sawicki JA, O'Brien TG. K6/ODC transgenic mice as a sensitive model for carcinogen identification. Toxicol Lett 2000; 116: 27-35.
3. Huang C, Ma WY, Li J, Goranson A, Dong Z. Requirement of Erk, but not JNK, for arsenite-induced cell transformation. J Biol Chem 1999; 274: 14595-14601.
4. Achanzar WE, Brambila EM, Diwan BA, Webber MM, Waalkes MP. Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. J Natl Cancer Inst 2002; 94: 1888-1891.
5. Ouyang W, Luo W, Zhang D, et al. PI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation. Environ Health Perspect 2008; 116: 1-6.
6. Ouyang W, Li J, Ma Q, Huang C. Essential roles of PI-3K/Akt/IKKbeta/NFkappaB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells. Carcinogenesis 2006; 27: 864-873.
7. Skinner HD, Zhong XS, Gao N, Shi X, Jiang BH. Arsenite induces p70S6K1 activation and HIF-1alpha expression in prostate cancer cells. Mol Cell Biochem 2004; 255: 19-23.
8. Dmitriev SE, Terenin IM, Dunaevsky YE, Merrick WC, Shatsky IN. Assembly of 48S translation initiation complexes from purified components with mRNAs that have some base pairing within their 5' untranslated regions. Mol Cell Biol 2003; 23: 8925-8933.
9. Holz MK, Ballif BA, Gygi SP, Blenis J. mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 2005; 123: 569-580.
10. Raught B, Gingras AC. Signaling to translation initiation. In: Mathews MB, Sonenberg N, Hershey JW, editors. Translational control in biology and medicine. New York: Cold Spring Harber Laboratory Press; 2007. pp. 369-400.
11. Schneider RJ, Sonenberg N. Translational control in cancer development and progression. In: Mathews MB, Sonenberg N, Hershey JW, editors. Translational control in biology and medicine. New York: Cold Spring Harbor Labortory Press; 2007. pp. 401-431.
12. Yang HS, Jansen AP, Nair R, et al. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 2001; 20: 669-676.
13. Wang Q, Sun Z, Yang HS. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene 2008; 27: 1527-1535.
14. Portereiko MF, Lloyd A, Steffen JG, Punwani JA, Otsuga D, Drews GN. AGL80 is required for central cell and endosperm development in arabidopsis. Plant cell 2006; 18: 1862-1872.
15. Colburn NH, Former BF, Nelson KA, Yuspa SH. Tumour promoter induces anchorage independence irreversibly. Nature 1979; 281: 589-591.
16. Colburn NH. Tumor promoter produces anchorage independence in mouse epidermal cells by an induction mechanism. Carcinogenesis 1980; 1: 951-954.
17. Rossman TG, Uddin AN, Burns FJ. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol Appl Pharmacol 2004; 198: 394-404.
18. Li J, Gorospe M, Barnes J, Liu Y. Tumor promoter arsenite stimulates histone H3 phosphoacetylation of proto-oncogenes c-fos and c-jun chromatin in human diploid fibroblasts. J Biol Chem 2003; 278: 13183-13191.
19. Woodgett JR. Recent advances in the protein kinase B signaling pathway. Curr Opin Cell Biol 2005; 17: 150-157.
20. Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon-Cardo C, Pandolfi PP. Identification of a tumour suppressor network opposing nuclear Akt function. Nature 2006; 441: 523-527.
21. Brognard J, Newton AC. PHLiPPing the switch on Akt and protein kinase C signaling. Trends Endocrinol Metab 2008; 19: 223-230.
22. Robert F, Pelletier J. Translation initiation: A critical signalling node in cancer. Expert Opin Ther Targets 2009; 13: 1279-1293.
23. van Gorp AG, van der Vos KE, Brenkman AB, et al. AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4B. Oncogene 2009; 28: 95-106.
24. Chen H, Liu J, Merrick BA, Waalkes MP. Genetic events associated with arsenic-induced malignant transformation: Applications of cDNA microarray technology. Mol Carcinog 2001; 30: 79-87.
25. Chen H, Liu J, Zhao CQ, Diwan BA, Merrick BA, Waalkes MP. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol Appl Pharmacol 2001; 175: 260-268.
26. Shahbazian D, Roux PP, Mieulet V, et al. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J 2006; 25: 2781-2791.
27. Pestova TV, Shatsky IN, Fletcher SP, Jackson RJ, Hellen CU. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev 1998; 12: 67-83.
28. Shahbazian D, Parsyan A, Petroulakis E, et al. Control of cell survival and proliferation by mammalian eukaryotic initiation factor 4B. Mol Cell Biol 2010; 30: 1478-1485.
29. Galmozzi E, Casalini P, Iorio MV, Casati B, Olgiati C, Menard S. HER2 signaling enhances 5'UTR-mediated translation of c-Myc mRNA. J Cell Physiol 2004; 200: 82-88.
30. Berkel HJ, Turbat-Herrera EA, Shi R, de Benedetti A. Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon. Cancer Epidemiol Biomarkers Prev 2001; 10: 663-666.
31. Shuda M, Kondoh N, Tanaka K, et al. Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res 2000; 20: 2489-2494.
32. Lazaris-Karatzas A, Montine KS, Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. Nature 1990; 345: 544-547.
33. Yang HS, Jansen AP, Komar AA, et al. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 2003; 23: 26-37.
34. Yang HS, Knies JL, Stark C, Colburn NH. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 2003; 22: 3712-3720.
35. Yang HS, Matthews CP, Clair T, et al. Tumorigenesis suppressor Pdcd4 down-regulates MAP4K1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 2006; 26: 1297-1306.
36. De Benedetti A, Harris AL. eIF4E expression in tumors: Its possible role in progression of malignancies. Int J Biochem Cell Biol 1999; 31: 59-72.
37. Lawson TG, Ray BK, Dodds JT, et al. Influence of 5' proximal secondary structure on the translational efficiency of eukaryotic mRNAs and on their interaction with initiation factors. J Biol Chem 1986; 261: 13979-13989.
38. Lawson TG, Lee KA, Maimone MM, et al. Dissociation of double-stranded polynucleotide helical structures by eukaryotic initiation factors as revealed by a novel assay. Biochemistry 1989; 28: 4729-4734.
39. Reichard JF, Schnekenburger M, Puga A. Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem Biophys Res Commun 2007; 352: 188-192.
40. Mass MJ, Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: A model for a mechanism of carcinogenesis. Mutat Res 1997; 386: 263-277.